Drugs / BHT-3021
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00453375 | Oct 2006 → May 2011 | diabetes mellitus, hypoglycemia | Bayhill Therapeutics | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BHT-3021 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00453375 ↗ |
| Route | Intramuscular | “weekly IM injections” NCT00453375 ↗ |